Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
May 14, 2014BoneKEy Reports

Osteoimmunology: oncostatin M as a pleiotropic regulator of bone formation and resorption in health and disease

View Full Paper
Ask AI
Bookmark
Share

Authors

NSNatalie A. SimsJQJ Quinn

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Sims et al. (2014) studied this question.

synapsesocial.com/papers/6a03f7cb74c8a788844d2706https://doi.org/10.1038/bonekey.2014.22
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Breast Cancer Cells Stimulate Neutrophils to Produce Oncostatin M: Potential Implications for Tumor Progression2005 · 412 citations
  2. 2Oncostatin M promotes osteogenesis and suppresses adipogenic differentiation of human adipose tissue‐derived mesenchymal stem cells2007 · 111 citations
  3. 3Oncostatin M Promotes Mammary Tumor Metastasis to Bone and Osteolytic Bone Degradation2012 · 77 citations
  4. 4Mechanisms of Oncostatin M-Induced Pulmonary Inflammation and Fibrosis2008 · 150 citations
  5. 5Catabolic Effects of Continuous Human PTH (1–38) in Vivo Is Associated with Sustained Stimulation of RANKL and Inhibition of Osteoprotegerin and Gene-Associated Bone Formation2001 · 429 citations